From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?-Reference-Cited by-同舟云学术

From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?

Published:2022-07-13 Issue:34 Volume:43 Page:3240-3242
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Bajaj Archna¹^ORCID,Cuchel Marina¹^ORCID

Affiliation:

1. Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, Pennsylvania , USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/43/34/3240/45669547/ehac338.pdf

Reference14 articles.

1. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014

2. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia;Kolansky;Am J Cardiol,2008

3. Supravalvular aortic stenosis and the risk of premature death among patients with homozygous familial hypercholesterolemia;Zhang;Am J Cardiol,2021

4. Homozygous Familial Hypercholesterolaemia International Clinical Collaborators. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study;Tromp;Lancet,2022

5. Systematic review and meta-analysis of aortic stenosis in homozygous familial hypercholesterolaemia: a shift in paradigm over nine decades;Belanger;Eur Heart J,2022

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in familial hypercholesterolemia;Advances in Clinical Chemistry;2024

2. TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?;European Heart Journal;2023-09-01

3. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia;BMC Medicine;2023-07-27

4. Targeting hypercholesterolaemia: challenges and opportunities;European Heart Journal;2023-07-01

5. Understanding aortic stenosis: advances in the identification of actionable pharmacological targets;European Heart Journal;2023-06-01